KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Return on Sales (2016 - 2025)

Historic Return on Sales for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to 0.06%.

  • Charles River Laboratories International's Return on Sales fell 100.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.01% for FY2024, which is 1100.0% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Return on Sales stood at 0.06%, which was down 100.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Return on Sales ranged from a high of 0.19% in Q4 2023 and a low of 0.21% during Q4 2024
  • Moreover, its 5-year median value for Return on Sales was 0.09% (2023), whereas its average is 0.08%.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 300bps in 2022, then crashed by -4000bps in 2024.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Return on Sales stood at 0.15% in 2021, then grew by 11bps to 0.17% in 2022, then grew by 8bps to 0.19% in 2023, then plummeted by -214bps to 0.21% in 2024, then surged by 126bps to 0.06% in 2025.
  • Its last three reported values are 0.06% in Q3 2025, 0.05% for Q2 2025, and 0.03% during Q1 2025.